501
Participants
Start Date
November 30, 2011
Primary Completion Date
July 31, 2016
Study Completion Date
May 23, 2018
Abbott Vascular XIENCE Everolimus Eluting Coronary Stent System
XIENCE implantation in the treatment of coronary artery disease.
Abbott Vascular ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System
ABSORB BVS implantation in the treatment of coronary artery disease.
Abbott Vascular International BVBA, Brussels
Lead Sponsor
Abbott Medical Devices
INDUSTRY